Favourable outcome of coronavirus disease 2019 in a1-year-old girl with acute myeloid leukaemia and severetreatment-induced immunosuppression
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic outbreak, it has emerged that the clinical course and outcome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is deﬁnitely more favourable in children than in adults. Few cases of infection in children with cancer are described; also in these patients,
except for one reported case, the disease was largely asymptomatic. Nevertheless, the management of COVID-19 in young patients with comorbidities, particularly cancer,
remains a challenge for the clinician; further data are required to optimise the clinical approach to these cases. A 13-month-old girl with high-risk acute myeloid leukaemia
was receiving chemotherapy in our clinic according to the Italian Association of Paediatric Haematology and Oncology Acute Myeloid Leukaemia 2013 protocol.
Read the full case report here.